Company Analysis

Tarsus Pharmaceuticals, Inc. (TARS)

Nasdaq: TARS · Biological Products, (No Diagnostic Substances) · Irvine, CA · filing with the SEC since 2020
Grade6.3
◀ Past 5.6● Present 7.0▶ Future 6.0
1 est.

Filings

227 filings since 2017 beside 449 insider forms · Large accelerated filer · read from EDGAR on Nov 13, 2026
Due nextLarge accelerated filer
10-K Annual report for the fiscal year ending Dec 31, 2026Large accelerated filers have 60 days after the fiscal year ends. by Mar 1, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Large accelerated filers have 40 days after the quarter ends; quarter ends are taken to the month end. by May 10, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 34 days after the quarter ended. The proxy statement was last filed Apr 28, 2026.

Filings a yearinsider forms included
5469811638397129
2020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 5 times in the last 36 months, the newest Jul 13, 2026.SEC letters: 2 in the last 36 months, the newest Nov 17, 2023.
Insider forms 449

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 5, 2026 SCHEDULE 13G Large holder notice
Nov 3, 2026 10-Q Quarterly report Sep 30, 2026
Nov 3, 2026 8-K items 2.02, 9.01 Results released · Current report
Oct 13, 2026 8-K/A item 9.01 Financial statements and exhibits · Current report, amended Sep 4, 2026
Oct 13, 2026 S-3ASR Shelf registration
Oct 13, 2026 S-3ASR Shelf registration
Sep 10, 2026 8-K items 2.01, 8.01, 9.01 Purchase or sale of a business completed; Other event · Current report Sep 4, 2026
Aug 13, 2026 SCHEDULE 13G/A Large holder update, amended
Aug 6, 2026 10-Q Quarterly report Jun 30, 2026
Aug 6, 2026 8-K items 2.02, 9.01 Results released · Current report
Aug 6, 2026 8-K items 1.01, 3.02, 8.01, 9.01 Major agreement signed; Shares sold without registration; Other event · Current report Aug 5, 2026
Aug 6, 2026 8-K items 1.01, 3.02, 8.01, 9.01 Major agreement signed; Shares sold without registration; Other event · Current report Jul 31, 2026
Jul 13, 2026 8-K item 5.02 Officer or director change · Current report
Jul 8, 2026 8-K items 1.01, 3.02, 8.01, 9.01 Major agreement signed; Shares sold without registration; Other event · Current report Jul 6, 2026
Jun 29, 2026 8-K item 5.07 Shareholder vote · Current report Jun 25, 2026
May 15, 2026 SCHEDULE 13G Large holder notice
May 15, 2026 SCHEDULE 13G/A Large holder update, amended
May 8, 2026 SCHEDULE 13G/A Large holder update, amended
May 6, 2026 10-Q Quarterly report Mar 31, 2026
May 6, 2026 8-K items 2.02, 9.01 Results released · Current report
May 6, 2026 SCHEDULE 13G/A Large holder update, amended
Apr 28, 2026 ARS Annual report to shareholders Dec 31, 2025
Apr 28, 2026 DEFA14A Extra proxy material
Apr 28, 2026 DEF 14A Proxy statement Jun 25, 2026
Mar 27, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 23, 2026 S-8 Employee stock plan registration
Feb 23, 2026 10-K Annual report Dec 31, 2025
Feb 23, 2026 8-K items 2.02, 9.01 Results released · Current report
Feb 18, 2026 8-K items 5.02, 9.01 Officer or director change · Current report
Feb 17, 2026 SCHEDULE 13G/A Large holder update, amended
Jan 12, 2026 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Nov 14, 2025 SCHEDULE 13G/A Large holder update, amended
Nov 4, 2025 10-Q Quarterly report Sep 30, 2025
Nov 4, 2025 8-K items 2.02, 9.01 Results released · Current report
Aug 14, 2025 SCHEDULE 13G/A Large holder update, amended
Aug 6, 2025 10-Q Quarterly report Jun 30, 2025
Aug 6, 2025 8-K items 2.02, 9.01 Results released · Current report
Jul 28, 2025 SCHEDULE 13G Large holder notice
Jun 18, 2025 8-K item 5.07 Shareholder vote · Current report Jun 12, 2025
May 15, 2025 SCHEDULE 13G/A Large holder update, amended
40 of 227 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton TARS · research, not advice